Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.14, 2003-01, pp. : 991-1000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QALYs: Are They Helpful to Decision Makers?

By McGregor Maurice

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 947-952

Adis International

Access to resources Recommend Favorite

Do Pharmacogenomic Tests Provide Value to Policy Makers?

By Ya-Chen Tina Shih

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1173-1177

Adis International

Access to resources Recommend Favorite

The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses: Fact or Fallacy?

By Donaldson C.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite

Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?

By Bala M.V.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 495-498

Adis International

Access to resources Recommend Favorite

The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?

By Brazier John E.

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 705-712

Adis International

Access to resources Recommend Favorite